Effects and Mechanisms of Danggui Buxue Decoction on Drug-induced Oxidative Hemolysis in Mice

REN De-wang; YE Ting-ting; NI Bi-hui; XU Ze-nan; CHEN Jia-jie; WEI Li-hao; LIN Xiao-hui; LIN Fan

doi:10.13422/j.cnki.syfjx.2014160135

您当前的位置：

首页 >

文章列表页 >

Effects and Mechanisms of Danggui Buxue Decoction on Drug-induced Oxidative Hemolysis in Mice

更新时间：2024-01-04

- Effects and Mechanisms of Danggui Buxue Decoction on Drug-induced Oxidative Hemolysis in Mice
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 16, Pages: 135-137(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2014160135
  CLC： R285.5
- Published：2014
- 稿件说明：
移动端阅览
REN De-wang, YE Ting-ting, NI Bi-hui, et al. Effects and Mechanisms of Danggui Buxue Decoction on Drug-induced Oxidative Hemolysis in Mice[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 135-137.
DOI：

REN De-wang, YE Ting-ting, NI Bi-hui, et al. Effects and Mechanisms of Danggui Buxue Decoction on Drug-induced Oxidative Hemolysis in Mice[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 135-137. DOI： 10.13422/j.cnki.syfjx.2014160135.

摘要

目的：观察当归补血汤对盐酸苯肼介导的小鼠氧化性溶血的治疗效果，并探讨其对红细胞抗氧化能力的影响。方法：采用盐酸苯肼（60 mg·kg-1）分别于第1，4，7天ip ICR小鼠，诱导氧化性溶血模型。实验设正常对照组、模型组、当归补血汤高、中、低剂量组（10，5，2.5 g·kg-1·d-1）和泼尼松组（0.005 g·kg-1·d-1），每组10只。给药干预后，观察当归补血汤对模型小鼠体重、红细胞数量（RBC）、血红蛋白（Hb）含量、红细胞超氧化物歧化酶（SOD）活性和丙二醛（MDA）含量的影响。结果：与正常对照组比较，模型组小鼠外周血红细胞的数量和Hb含量显著下降，MDA增加，SOD活性下降（P<0.01或P<0.05）。相对于模型组，当归补血汤可增加模型小鼠红细胞的数量、提高Hb含量、降低MDA水平以及增强SOD活性（P<0.01或P<0.05）。结论：当归补血汤对盐酸苯肼介导的氧化性溶血具有良好的疗效，其作用机制可能与促进机体造血机能，增强红细胞抗氧化能力和拮抗氧化剂对红细胞的损伤有关。

Abstract

Objective: To observe the effects of Danggui Buxue decoction (DGBXD) on phenylhydrazine hydrochloride-induced oxidative hemolysis and investigate its mechanism related to antioxidant capacity in mice. Method: The mouse model of oxidative hemolysis was established by intraperitoneal injection of phenylhydrazine hydrochloride. Mice were divided into normal group

model group

DGBXD high

medium and low dose groups (10

2.5 g· kg-1· d-1) and prednisone treatment group (0.005 g· kg-1· d-1). Then

the effects of DGBXD on model mice were observed. The contents of hemoglobin(Hb) and red cell malondialdehyde (MDA) were measured. The numbers of red blood cells (RBC) and activity of superoxide dismutase (SOD) was also determined and the body weight was analyzed. Result: Compared with the control group

the number of RBC

level of Hb and activity of SOD were significantly decreased in the model group (P<0.01 or P<0.05)

the content of MDA in RBC was markedly increased in mice model with oxidative hemolysis (P<0.05). Compared with the model group

DGBXD could increase the number of RBC and level of Hb

decrease the content of MDA and raise the activity of SOD in RBC (P<0.01 or P<0.05). Conclusion: DGBXD has good efficacy in treating drug-induced oxidative hemolysis in mice. Its mechanism might be related to the promotion of hematopoietic function

enhancing red cell antioxidant capacity and protection of erythrocytes against oxidative damage.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Role of Oxidative Stress in Ulcerative Colitis and Traditional Chinese Medicine Prevention and Treatment： A Review

Effect of Nitrogen Application on Antioxidant Enzyme System of Acanthopanax senticosus

Effects of JQYXKL on Hematopoiesis and Physical Strength in Qi-Xue Deficiency Mice

Effect of Extract on Blood Pressure and Lipid Peroxidation of Target-organ in Renal Hypertension Rats

Effect of Dahuang Zhechong Wan on Formation Stage of Pulmonary Fibrosis in Rats

Related Author

CHEN Bo

SUN Xitong

DONG Xinqian

WANG Wei

SONG Hongquan

ZHAO Jiting

ZHENG Ya

ZHANG Honghao

Related Institution

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Shandong University of Traditional Chinese Medicine

School of Forestry, Northeast Forestry University

School of Pharmacy, Heilongjiang University of Chinese Medicine

The First Affiliate Hospital of Clinical Medicine of Guangdong Pharmaceutical University

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰